Who is sponsoring NCT06232304?

NCT06232304 is sponsored by Michigan State University.

What drugs are being tested in NCT06232304?

Interventions in NCT06232304: TEACH.

What condition does NCT06232304 study?

NCT06232304 studies Systemic Lupus Erythematosus of Childhood (Disorder).

Is NCT06232304 still recruiting?

NCT06232304 is currently recruiting now. Last updated 30 October 2025.

Last reviewed 2025-10-30 · How we verify

NCT06232304: cSLE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

Recruiting now NA Last updated 30 October 2025

What this trial tests

NA trial testing TEACH in Systemic Lupus Erythematosus of Childhood (Disorder) in 175 participants. Currently enrolling.

Timeline

12 September 2024

Primary endpoint
1 April 2027

30 September 2027

Quick facts

Lead sponsor	Michigan State University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	175
Start date	12 September 2024
Primary completion	1 April 2027
Estimated completion	30 September 2027
Sites	7 locations across Canada, United States

Drugs / interventions tested

TEACH

Conditions studied

Systemic Lupus Erythematosus of Childhood (Disorder) — all drugs for Systemic Lupus Erythematosus of Childhood (Disorder) →

Sponsor

Michigan State University

Who can join

Adults 12 to 22, any sex, with Systemic Lupus Erythematosus of Childhood (Disorder). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of TEACH

Trials testing the same drug.

NCT04335643 — Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus · NA · completed

Other Michigan State University trials

Trials by the same sponsor.

NCT06325150 — The Impact of Light Exposure on Cognitive Function in Classrooms · Phase 1 · not yet recruiting
NCT07213284 — Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial · NA · not yet recruiting
NCT07164391 — Empowering Vietnamese Americans · NA · not yet recruiting
NCT04521972 — Impact of Room Light on Uterine Contractions and Labor Progression in Pregnancy · NA · recruiting
NCT05358964 — Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the Black Community · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06232304 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Michigan State University
Last refreshed: 30 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06232304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing